Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
about
Promising oncolytic agents for metastatic breast cancer treatmentCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesIdentification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replicationOncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cellsOncolytic herpes viruses, chemotherapeutics, and other cancer drugsCombination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatmentA classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.Anaplastic thyroid cancer: a comprehensive review of novel therapy.Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Evolution of oncolytic viruses: novel strategies for cancer treatment.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.Oncolytic virotherapy for urological cancers.Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models.Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1.Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.Model-based rational design of an oncolytic virus with improved therapeutic potential.Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.
P2860
Q26830620-85377688-033B-40E1-B23B-A58F6B3EF59CQ26863779-BB701824-281A-4CAE-94C4-181A8244F325Q33566587-4B6CE8D3-019C-4EE3-9E41-46794C1C886FQ33995471-980415F2-24D3-4A0F-934D-DD7196D0CA1FQ35545752-526216F8-4E8E-40BA-A96C-EC7E1C2F05DEQ37031896-7FE7B217-03E6-4DE3-99CB-7E02157ED7B8Q37160195-B34DB161-C76F-4FEA-BA67-FC23A278662FQ37565501-A8F90B8E-F83E-41E9-A44B-E0E19747837AQ37854708-9FC81022-AA3D-48D2-A7CA-61A09A95B1A4Q37899223-4B9C65FE-E220-48AB-9A37-D5DC119EC556Q38159802-A2E2530F-213F-41E0-89AF-9F4FF8EBC172Q38264652-5BFE3F9D-DFF8-47DB-B477-0021E6B50940Q38765125-920CF2CF-3836-460D-9DBA-6769EAA7D009Q38842126-43D64F0C-60CF-47CC-BC8A-8D7891A97B7CQ39247534-1792E953-1D1F-4819-85B0-38A33EAF2D32Q39315516-E4A970B4-89F8-4397-AD02-534D8FDB8E2DQ39325959-24D37AFD-3903-4064-B308-B69AA5F78CE2Q39519074-4839586B-1EF9-443B-A001-4185C04A1D17Q39745964-4D1B25BD-9373-4F70-843A-81C52E61F71AQ45350759-5556004B-F74F-4DF8-9656-A46BB885ED42Q45360866-C5C45506-6EFE-4975-B4EA-1A62AB6988EC
P2860
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
@en
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
@nl
type
label
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
@en
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
@nl
prefLabel
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
@en
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
@nl
P2093
P2860
P50
P1476
Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer
@en
P2093
Paramjeet Singh
Richard J Wong
Sizhi Paul Gao
Ting-Chao Chou
P2860
P304
P356
10.1158/1078-0432.CCR-07-4628
P407
P577
2008-03-01T00:00:00Z